The CAS9 technology market is undergoing a transformative phase characterized by rapid innovations and advancements in biotechnology. Forecasts indicate that the market will expand to an impressive USD 11.1 billion by 2035, driven by a compound annual growth rate (CAGR) of 9.82%. This growth reflects not only the technological evolution within the sector but also the increasing applications...